Mouse Monoclonal to CD13 / Aminopeptidase N View larger

Mouse Monoclonal to CD13 / Aminopeptidase N

New product

107,80 € tax excl.

Customer ratings and reviews

Nobody has posted a review yet
in this language

Data sheet of Mouse Monoclonal to CD13 / Aminopeptidase N

BrandExbio
Product typePrimary antibodies
ReactivityHuman, Non-Human Primates
ClonalityMonoclonal

More info about Mouse Monoclonal to CD13 / Aminopeptidase N

Brand: Exbio
Product no.: 11-396-C025
Product type: Primary antibodies
Host species: Mouse
Product name: Mouse Monoclonal to CD13 / Aminopeptidase N
Antigen: CD13
Clonality: Monoclonal
Clone: WM15
Isotype: IgG1
Immunogen: Human AML cells
Format: purified
Specificity: The antibody WM15 recognises the human CD13 cell surface glycoprotein, a 150 kDa molecule expressed on granulocytes, endothelial cells, epithelial cells and myeloid progenitors.
_x000D_ HLDA III; WS Code M 213
_x000D_ HLDA IV; WS Code M 44
_x000D_ HLDA IV; WS Code M 209
_x000D_ HLDA V; WS Code M MA191
Categories: CD Antigens & MHC (Veterinary), CD and Related Antigens (Human)
Concentration: 1 mg/ml
Storage buffer: Phosphate buffered saline (PBS) with 15 mM sodium azide, approx. pH 7.4
Storage / stability: Store at 2-8°C. Do not freeze. Do not use after expiration date stamped on vial label.
Background: CD13 (aminopeptidase N, APN) is a 150 kDa type II transmembrane zinc-binding ectopeptidase expressed on various cell types. This metalloprotease preferentially catalyzes removal of neutral amino acids from small peptides, thus activating or inactivating bioactive peptides. CD13 has also role in extracellular matrix degradation, antigen processing and signal transduction, is important in inflammatory responses, regulates intercellular contact, cell motility and vascularization. CD13 is involved in protection of leukemic cells against apoptosis and its expression associated with poor prognosis of carcinomas.
Purity: > 95% (by SDS-PAGE)
Purification: Purified by protein-A affinity chromatography
Product specific references: *Favaloro EJ, Browning T, Facey D: CD13 (GP150; aminopeptidase-N): predominant functional activity in blood is localized to plasma and is not cell-surface associated. Exp Hematol. 1993 Dec;21(13):1695-701. _x000D_ , *Bradstock KF, Favaloro EJ, Kabral A, Kerr A, Hughes WG, Musgrove E: Myeloid progenitor surface antigen identified by monoclonal antibody. Br J Haematol. 1985 Sep;61(1):11-20. _x000D_ , *Bradstock KF, Favaloro EJ, Kabral A, Kerr A, Hughes WG, Berndt MC, Musgrove E: Human myeloid differentiation antigens identified by monoclonal antibodies: expression on leukemic cells. Pathology. 1985 Jul;17(3):392-9. _x000D_ , *McCormack E, Mujic M, Osdal T, Bruserud O, Gjertsen BT: Multiplexed mAbs: a new strategy in preclinical time-domain imaging of acute myeloid leukemia. Blood. 2013 Feb 14;121(7):e34-42. doi: 10.1182/blood-2012-05-429555., *Leukocyte Typing III., McMichael A.J. et al. (Eds.), Oxford University Press (1987)., *Leukocyte Typing IV., Knapp W. et al. (Eds.), Oxford University Press (1989)., *Leukocyte Typing V., Schlossman S. et al. (Eds.), Oxford University Press (1995).
General references: *Terauchi M, Kajiyama H, Shibata K, Ino K, Nawa A, Mizutani S, Kikkawa F. Inhibition of APN/CD13 leads to suppressed progressive potential in ovarian carcinoma cells. BMC Cancer. 2007 Jul 27;7:140._x000D_ _x000D_ _x000D_ , *Petrovic N, Schacke W, Gahagan JR, O'Conor CA, Winnicka B, Conway RE, Mina-Osorio_x000D_ P, Shapiro LH. CD13/APN regulates endothelial invasion and filopodia formation. Blood. 2007 Jul 1;110(1):142-50._x000D_ _x000D_ , *Tokuhara T, Hattori N, Ishida H, Hirai T, Higashiyama M, Kodama K, Miyake M. Clinical significance of aminopeptidase N in non-small cell lung cancer. Clin Cancer Res. 2006 Jul 1;12(13):3971-8._x000D_
Related products: - Mouse Monoclonal to CD135
- Mouse Monoclonal to CD133
- Mouse Monoclonal to CD134
Shipping condition: Room temperature

Reviews

Buy Mouse Monoclonal to CD13 / Aminopeptidase N now

Add to cart